CARDIFF ONCOLOGY, INC. Investing Cash Flow
CARDIFF ONCOLOGY, INC. (CRDF) reported Investing Cash Flow of $15.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $12.27M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $3.26M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $10.75M, a 138.28% increase year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $10.16M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2025 was $1.34M, a 90.22% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2024 was $13.73M, a 62.07% decline from fiscal 2023.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2023 was $36.20M, a 5.12% decline from fiscal 2022.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) investing activities for fiscal 2022 was $38.15M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $15.53M 10-Q · filed 2026-08-11 | $26.27M derived: sum of 3 quarters · filed 2026-08-11 | $36.44M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $3.26M 10-Q · filed 2026-05-14 | $14.01M derived: sum of 2 quarters · filed 2026-05-14 | $24.17M derived: sum of 3 quarters · filed 2026-05-14 | $19.18M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.91M derived: sum of 2 quarters · filed 2026-02-24 | $15.93M derived: sum of 3 quarters · filed 2026-08-11 | $1.34M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $10.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.18M derived: sum of 2 quarters · filed 2026-08-11 | -$9.41M 10-Q · filed 2025-11-06 | -$4.90M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$19.57M 10-Q · filed 2026-08-11 | -$15.06M derived: sum of 3 quarters · filed 2026-08-11 | -$24.49M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$14.58M 10-Q · filed 2026-05-14 | -$10.07M derived: sum of 2 quarters · filed 2026-05-14 | -$19.51M derived: sum of 3 quarters · filed 2026-05-14 | -$5.49M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$4.92M derived: sum of 2 quarters · filed 2026-02-24 | $9.09M derived: sum of 3 quarters · filed 2026-02-24 | $13.73M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | -$9.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.58M derived: sum of 2 quarters · filed 2025-11-06 | $9.22M 10-Q · filed 2025-11-06 | $22.78M derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $14.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $18.65M 10-Q · filed 2025-07-29 | $32.21M derived: sum of 3 quarters · filed 2025-07-29 | $36.03M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2024-03-31 | $4.64M 10-Q · filed 2025-05-08 | $18.20M derived: sum of 2 quarters · filed 2025-05-08 | $22.02M derived: sum of 3 quarters · filed 2025-05-08 | $33.50M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $13.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $17.38M derived: sum of 2 quarters · filed 2025-02-27 | $28.87M derived: sum of 3 quarters · filed 2025-02-27 | $36.20M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $15.30M derived: sum of 2 quarters · filed 2024-11-07 | $22.63M 10-Q · filed 2024-11-07 | $29.65M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $11.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $18.81M 10-Q · filed 2024-08-08 | $25.83M derived: sum of 3 quarters · filed 2024-08-08 | $31.00M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $7.33M 10-Q · filed 2024-05-02 | $14.35M derived: sum of 2 quarters · filed 2024-05-02 | $19.51M derived: sum of 3 quarters · filed 2024-05-02 | $27.12M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | $7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $12.18M derived: sum of 2 quarters · filed 2024-02-29 | $19.79M derived: sum of 3 quarters · filed 2024-02-29 | $38.15M 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $12.77M derived: sum of 2 quarters · filed 2023-11-02 | $31.13M 10-Q · filed 2023-11-02 | $22.34M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $7.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $25.97M 10-Q · filed 2023-08-09 | $17.17M derived: sum of 3 quarters · filed 2023-08-09 | $25.22M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $18.36M 10-Q · filed 2023-05-04 | $9.56M derived: sum of 2 quarters · filed 2023-05-04 | $17.61M derived: sum of 3 quarters · filed 2023-05-04 | -$1.39M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | -$8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$745.00K derived: sum of 2 quarters · filed 2023-03-02 | -$19.75M derived: sum of 3 quarters · filed 2023-03-02 | -$131.45M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$10.96M derived: sum of 2 quarters · filed 2022-11-03 | -$122.65M 10-Q · filed 2022-11-03 | -$122.71M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$130.70M 10-Q · filed 2022-08-04 | -$130.76M derived: sum of 3 quarters · filed 2022-08-04 | -$130.91M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | -$111.70M 10-Q · filed 2022-05-05 | -$111.75M derived: sum of 2 quarters · filed 2022-05-05 | -$111.91M derived: sum of 3 quarters · filed 2022-05-05 | -$111.91M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$211.00K derived: sum of 2 quarters · filed 2022-02-24 | -$211.00K derived: sum of 3 quarters · filed 2022-02-24 | -$211.00K 10-K · filed 2022-02-24 | -$211.88K 10-K · filed 2021-02-25 | |
| 2020-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$154.00K derived: sum of 2 quarters · filed 2021-11-04 | -$154.00K 10-Q · filed 2021-11-04 | -$153.78K 10-Q · filed 2020-11-05 | -$154.00K derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-08-05 | -$62.35K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-05-06 | -$62.35K derived: sum of 3 quarters · filed 2021-05-06 | -$62.35K derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$62.35K derived: sum of 2 quarters · filed 2021-02-25 | -$62.35K derived: sum of 3 quarters · filed 2021-02-25 | -$67.62K 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$62.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$62.35K derived: sum of 2 quarters · filed 2020-11-05 | -$67.62K 10-Q · filed 2020-11-05 | -$67.62K derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$5.27K 10-Q · filed 2020-08-11 | -$5.27K derived: sum of 3 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$5.27K 10-Q · filed 2020-05-07 | -$5.27K derived: sum of 2 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $22.84K 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | $22.84K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |